Maryam Oskoui

NMD4C investigator Dr Maryam Oskoui profile picture


Director, Division of Pediatric Neurology, Department of Pediatric, Montreal Children’s Hospital

Associate Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre

NMD4C Working Group(s): Knowledge Translation

Email Maryam


Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Clinician Scientist and Director of Pediatric Neurology at the Montreal Children’s Hospital. She is a Senior Clinical Research Scholar of the FRQ-S with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR.


Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. As part of NMD4C, she is developing clinical guidelines through the Knowledge Translation Team. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and chairing the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec.


Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University.

Recent Publications

Groulx-Boivin, E, Osman, H, Chakraborty, P, Lintern, S, Oskoui, M, Selby, K et al.. Variability in newborn screening across Canada: spinal muscular atrophy and beyond. Can J Neurol Sci. 2023. 1-19 PMID:36892082

Oskoui, M, Day, JW, Deconinck, N, Mazzone, ES, Nascimento, A, Saito, K et al.. Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA). J Neurol. 2023. 1-16 PMID:36735057

Ahmed, A, Rosella, LC, Oskoui, M, Watson, T, Yang, S. In utero Exposure to Maternal Diabetes and the Risk of Cerebral Palsy: A Population-based Cohort Study. Epidemiology. 2023.34 (2)247-258 PMID:36722807

Rouabhi, A, Husein, N, Dewey, D, Letourneau, N, Daboval, T, Oskoui, M et al.. Development of a Bedside Tool to Predict the Diagnosis of Cerebral Palsy in Term-Born Neonates. JAMA Pediatr. 2023.177 (2)177-186 PMID:36648921

Eisman, S, Husein, N, Fehlings, D, Andersen, J, Oskoui, M, Shevell, M et al.. Early Biomarkers in the Prediction of Later Functional Impairment in Term Children with Cerebral Palsy. Pediatr Neurol. 2023.140 59-64 PMID:36640520

See more on PubMed